Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Arthrex Endoscopy EMEAArthrex Endoscopy EMEA
VS
Edwards LifesciencesEdwards Lifesciences
Arthrex Endoscopy EMEA

Arthrex Endoscopy EMEA

N/A

Last Update: 29/01/2026

View Profile
760/1000Fair

Arthrex Endoscopy is a division of Arthrex Inc., a global orthopedic medical device manufacturer. We specialize in minimally invasive procedures in surgical endoscopy, drawing on over 40 years of Arthrex innovation in medical devices. Our 4K imaging systems, rigid endos...

NAICS:3391
NAICS Definition:Medical Equipment and Supplies Manufacturing
Employees:None
Subsidiaries:25
12-month incidents
0
Known data breaches
0
Attack type number
0
Edwards Lifesciences

Edwards Lifesciences

One Edwards Way, Irvine, 92614, US

Last Update: 11/09/2026

View Profile
Between 800 and 849
http://www.edwards.com
818/1000Good

Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees ...

NAICS:3391
NAICS Definition:Medical Equipment and Supplies Manufacturing
Employees:13,672
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Arthrex Endoscopy EMEA

Arthrex Endoscopy EMEA

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Edwards Lifesciences

Edwards Lifesciences

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Medical Equipment Manufacturing Industry Avg (This Year)

No incidents recorded for Arthrex Endoscopy EMEA in 2026.

Incidents

Incidents vs Medical Equipment Manufacturing Industry Avg (This Year)

No incidents recorded for Edwards Lifesciences in 2026.

Incidents

Incident History - Arthrex Endoscopy EMEA (X = Date, Y = Severity)

Arthrex Endoscopy EMEA cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Edwards Lifesciences (X = Date, Y = Severity)

Edwards Lifesciences cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Arthrex Endoscopy EMEA

Arthrex Endoscopy EMEA

Incidents
No explicit notable incidents reported.
Edwards Lifesciences

Edwards Lifesciences

Incidents
No explicit notable incidents reported.

FAQ

Between Arthrex Endoscopy EMEA company and Edwards Lifesciences company, which one has the best AI Cybersecurity Score ?
Between Arthrex Endoscopy EMEA company and Edwards Lifesciences company, which one has experienced more cyber incidents in the past ?
Between Arthrex Endoscopy EMEA company and Edwards Lifesciences company, which one has experienced more cyber incidents this year ?
Between Arthrex Endoscopy EMEA company and Edwards Lifesciences company, which one has experienced at least one ransomware attack ?
Between Arthrex Endoscopy EMEA company and Edwards Lifesciences company, which one has experienced at least one data breach ?
Between Arthrex Endoscopy EMEA company and Edwards Lifesciences company, which one has experienced at least one targeted cyberattack ?
Between Arthrex Endoscopy EMEA company and Edwards Lifesciences company, which one has experienced at least one vulnerability ?
Between Arthrex Endoscopy EMEA company and Edwards Lifesciences company, which one holds the most compliance certifications ?
Between Arthrex Endoscopy EMEA company and Edwards Lifesciences company, which one holds the fewest compliance certifications ?
Between Arthrex Endoscopy EMEA company and Edwards Lifesciences company, which one has the most subsidiaries ?
Between Arthrex Endoscopy EMEA company and Edwards Lifesciences company, which one has the largest number of employees ?
Between Arthrex Endoscopy EMEA and Edwards Lifesciences, which company holds both SOC 2 Type 1 certifications ?
Between Arthrex Endoscopy EMEA and Edwards Lifesciences, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Arthrex Endoscopy EMEA or Edwards Lifesciences ?
Which company is PCI DSS compliant - Arthrex Endoscopy EMEA or Edwards Lifesciences ?
Between Arthrex Endoscopy EMEA and Edwards Lifesciences, which company complies with HIPAA regulations for healthcare data ?
Between Arthrex Endoscopy EMEA and Edwards Lifesciences, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-96451
SUMMARY

Authorization Bypass Through User-Controlled Key vulnerability in Ultimate Member Ultimate Member ultimate-member allows Privilege Escalation.This issue affects Ultimate Member: from n/a through 2.13.1.

PUBLISHED
Date2026-10-03
UPDATED
Date2026-10-03
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-103342
SUMMARY

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Unlimited Elements Unlimited Elements For Elementor (Free Widgets, Addons, Templates) unlimited-elements-for-elementor allows Reflected XSS.This issue affects Unlimited Elements For Elementor (Free Widgets, Addons, Templates): from n/a through 2.0.20.

PUBLISHED
Date2026-10-03
UPDATED
Date2026-10-03
RISK INFORMATION (Score: 7.1)
CVSS3
Base Score: 7.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L
IMPACT SCORE
3.7
EXPLOITABILITY
2.8
CVE-2026-103065
SUMMARY

Improper Validation of Specified Quantity in Input vulnerability in Themeum Kirki kirki allows Accessing Functionality Not Properly Constrained by ACLs.This issue affects Kirki: from n/a through 6.3.1.

PUBLISHED
Date2026-10-03
UPDATED
Date2026-10-03
RISK INFORMATION (Score: 8.2)
CVSS3
Base Score: 8.2
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:N
IMPACT SCORE
4.2
EXPLOITABILITY
3.9
CVE-2026-105122
SUMMARY

OpenAM before 16.1.3 contains a server-side request forgery vulnerability that allows attackers able to register or modify OAuth 2.0 clients to make OpenAM fetch internal resources via an unvalidated jwks_uri. Attackers can trigger unauthenticated fetches through client-authentication and ID-token validation to probe internal hosts, metadata endpoints or local files, or exhaust request threads for denial of service.

PUBLISHED
Date2026-10-03
UPDATED
Date2026-10-03
RISK INFORMATION (Score: 5.4)
CVSS3
Base Score: 5.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
2.5
EXPLOITABILITY
2.8
CVE-2026-105121
SUMMARY

OpenAM before 16.1.3 contains an improper authorization vulnerability that allows delegated administrators to destroy sessions outside their realms because realm checks use the requester's realm. Authenticated accounts holding the iplanet-am-session-destroy-sessions attribute can supply a target session identifier or handle to forcibly log out users in any realm.

PUBLISHED
Date2026-10-03
UPDATED
Date2026-10-03
RISK INFORMATION (Score: 4.9)
CVSS3
Base Score: 4.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
1.2